Bladder cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Bladder cancer}} | {{Bladder cancer}} | ||
{{SCC}} | {{SCC}}; {{AE}} {{Rim}} | ||
==Overview== | ==Overview== | ||
In the United States, bladder cancer is the fourth most common type of cancer in men and the ninth most common cancer in women. More than 47,000 men and 16,000 women are diagnosed with bladder cancer each year. One reason for its higher incidence in men is that the [[androgen receptor]], which is much more active in men than in women, plays a major part in the development of the cancer.<ref>{{cite news | first= | last= | coauthors= | title=Scientists Find One Reason Why Bladder Cancer Hits More Men | date=April 20 2007 |publisher=University of Rochester Medical Center | url =http://www.urmc.rochester.edu/pr/news/story.cfm?id=1436 | work = | pages = |is who want kill others accessdate = 2007-04-20 | language = }}</ref> | In the United States, bladder cancer is the fourth most common type of cancer in men and the ninth most common cancer in women. More than 47,000 men and 16,000 women are diagnosed with bladder cancer each year. One reason for its higher incidence in men is that the [[androgen receptor]], which is much more active in men than in women, plays a major part in the development of the cancer.<ref>{{cite news | first= | last= | coauthors= | title=Scientists Find One Reason Why Bladder Cancer Hits More Men | date=April 20 2007 |publisher=University of Rochester Medical Center | url =http://www.urmc.rochester.edu/pr/news/story.cfm?id=1436 | work = | pages = |is who want kill others accessdate = 2007-04-20 | language = }}</ref> | ||
==Epidemiology and Demographics== | |||
===Prevalence=== | |||
* In the United States, the age-adjusted [[prevalence]] of (insert disease name here) is 0.1305% in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
===Incidence=== | |||
* The delay-adjusted [[incidence]] of (insert disease name here) in 2011 was estimated to be 20.74 per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
* In 2011, the age-adjusted [[incidence]] of (insert disease name here) was 20.13 per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
===Age=== | |||
* While the overall age-adjusted [[incidence]] of (insert disease name here) in the United States between 2007 and 2011 is 20.5 per 100,000, the age-adjusted [[incidence]] of (insert disease name here) by age category is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
** Under 65 years: 5.4 per 100,000 | |||
** 65 and over: 124.7 per 100,000 | |||
===Gender=== | |||
* In the United States, the age-adjusted [[prevalence]] of (insert disease name here) by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
** In males: 0.2289% | |||
** In females: 0.0566% | |||
* In the United States, the delay-adjusted [[incidence]] of (insert disease name here) by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
** In males: 36.24 per 100,000 persons | |||
** In females: 8.98 per 100,000 persons | |||
* In the United States, the age-adjusted [[incidence]] of (insert disease name here) by gender on 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
** In males: 35.18 per 100,000 persons | |||
** In females: 8.72 per 100,000 persons | |||
* Shown below is an image depicting the delay-adjusted [[incidence]] and observed [[incidence]] of (insert disease name here) by gender and race in the United States between 1975 and 2011. These graphs are adapted from [[SEER]]: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
[Insert figure x.1 from the report] | |||
===Race=== | |||
* Shown below is a table depicting the age-adjusted [[prevalence]] of (insert disease name here) by race in 2011 in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Asian/Pacific Islander''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic''' | |||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Age-adjusted [[prevalence]]'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.1305%||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.1482%||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 0.0620%||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 0.0587%||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.0644% | |||
|} | |||
* In the United States, the race that is most susceptible to developing this disease/condition, is the ____ race.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
* Shown below is an image depicting the [[incidence]] of (insert disease name here) by race in the United States between YEAR and YEAR.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
[Insert figure x.2 from the report] | |||
<small> API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native</small> | |||
==References== | ==References== | ||
Revision as of 20:22, 11 June 2014
|
Bladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bladder cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Bladder cancer epidemiology and demographics |
|
Risk calculators and risk factors for Bladder cancer epidemiology and demographics |
Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [1]
Overview
In the United States, bladder cancer is the fourth most common type of cancer in men and the ninth most common cancer in women. More than 47,000 men and 16,000 women are diagnosed with bladder cancer each year. One reason for its higher incidence in men is that the androgen receptor, which is much more active in men than in women, plays a major part in the development of the cancer.[1]
Epidemiology and Demographics
Prevalence
- In the United States, the age-adjusted prevalence of (insert disease name here) is 0.1305% in 2011.[2]
Incidence
- The delay-adjusted incidence of (insert disease name here) in 2011 was estimated to be 20.74 per 100,000 persons in the United States.[2]
- In 2011, the age-adjusted incidence of (insert disease name here) was 20.13 per 100,000 persons in the United States.[2]
Age
- While the overall age-adjusted incidence of (insert disease name here) in the United States between 2007 and 2011 is 20.5 per 100,000, the age-adjusted incidence of (insert disease name here) by age category is:[2]
- Under 65 years: 5.4 per 100,000
- 65 and over: 124.7 per 100,000
Gender
- In the United States, the age-adjusted prevalence of (insert disease name here) by gender in 2011 is:[2]
- In males: 0.2289%
- In females: 0.0566%
- In the United States, the delay-adjusted incidence of (insert disease name here) by gender in 2011 is:[2]
- In males: 36.24 per 100,000 persons
- In females: 8.98 per 100,000 persons
- In the United States, the age-adjusted incidence of (insert disease name here) by gender on 2011 is:[2]
- In males: 35.18 per 100,000 persons
- In females: 8.72 per 100,000 persons
- Shown below is an image depicting the delay-adjusted incidence and observed incidence of (insert disease name here) by gender and race in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[2]
[Insert figure x.1 from the report]
Race
- Shown below is a table depicting the age-adjusted prevalence of (insert disease name here) by race in 2011 in the United States.[2]
| All Races | White | Black | Asian/Pacific Islander | Hispanic | |
| Age-adjusted prevalence | 0.1305% | 0.1482% | 0.0620% | 0.0587% | 0.0644% |
- In the United States, the race that is most susceptible to developing this disease/condition, is the ____ race.[2]
- Shown below is an image depicting the incidence of (insert disease name here) by race in the United States between YEAR and YEAR.[2]
[Insert figure x.2 from the report]
API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native
References
- ↑ "Scientists Find One Reason Why Bladder Cancer Hits More Men". University of Rochester Medical Center. April 20 2007. Unknown parameter
|is who want kill others accessdate=ignored (help); Check date values in:|date=(help) - ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.